⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S1 from Immune marker spatial distribution and clinical outcome after PD-1 blockade in mismatch repair-deficient, advanced colorectal carcinomas

Bahar Saberzadeh-Ardestani Rondell P. Graham Sara McMahon Eze Ahanonu Qian Shi Crystal Williams Antony Hubbard Wenjun Zhang Andrea Murányi Dongyao Yan Zhaohui Jin Kandavel Shanmugam Frank A. Sinicrope

View at Publisher

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S1. PD-L1 (green) was expressed in (A) CD3+ T lymphocytes (magenta/pink), (B) CD68+ macrophages (red), panCK+ (cyan/light blue) tumor cells, and (C) tumor cells (red). PD-1 expression on CD8+ T lymphocytes was also observed.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Saberzadeh-Ardestani et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db64358752380c https://doi.org/10.1158/1078-0432.27034219

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S1 from Immune marker spatial distribution and clinical outcome after PD-1 blockade in mismatch repair-deficient, advanced colorectal carcinomas2024
2Supplementary Figure S2 from Immune marker spatial distribution and clinical outcome after PD-1 blockade in mismatch repair-deficient, advanced colorectal carcinomas2024
3Supplementary Figure S2 from Immune marker spatial distribution and clinical outcome after PD-1 blockade in mismatch repair-deficient, advanced colorectal carcinomas2024
4Data from Immune marker spatial distribution and clinical outcome after PD-1 blockade in mismatch repair-deficient, advanced colorectal carcinomas2024
5Spatially resolved multi-region proteomics for prediction of clinical outcome in deficient mismatch repair metastatic colorectal cancer treated with PD-1 blockade.2024

Supplementary Figure S9 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer2025
FIGURE 2 from Exhausted Tumor-infiltrating CD39<sup>+</sup>CD103<sup>+</sup> CD8<sup>+</sup> T Cells Unveil Potential for Increased Survival in Human Pancreatic Cancer2024
Spatial Dynamics Links PD-L1 and Tumor-Associated Macrophage-Enriched Niches to Immune and Mesenchymal States in Microsatellite-Stable Colorectal Cancer2026